Compliance4All, Online
2017-01-24
Overview: This 90 minute training course will provide your company the opportunity
for comprehensive understanding of the IMPD (Investigational Medicinal
Product Dossier) and the structure and content differences between a EU
CTA Application and an FDA IND Application.
Why you should attend: All sponsors, CROs, Sites and auditors of Clinical Research who are
involved in pharmaceutical or biological development need to possess the
knowledge and be efficient in completing successful applications for their
studies. Knowing what is expected of you and "getting-it-right" the first
time, will allow faster development of innovative products.
Areas Covered In the Session: US FDA and EU Agency Orientation / Structure Start –Up and Conducting Clinical Trial Processes Following Product Registration / Licensing Options Company Strategy- Linking Clinical Trials & Marketing Authorization
Applications
Who will benefit: This Webinar will provide invaluable assistance to all personnel in the
Pharmaceutical, Biotechnology and CRO industry conducting Clinical
Trials including: Sponsor Senior management Project Managers Clinical Trial Heads Medical writers
|